Company

Guardant Health Inc.

GHBiotechnology

Guardant Health Inc. is a precision oncology company that specializes in liquid biopsy tests for cancer detection, monitoring, and treatment. The company’s flagship product, Guardant360, drives revenue through diagnostic testing and strateg

Snapshot

Guardant Health Inc. is a biotechnology company that has completed 2 disclosed acquisitions and reported $982M in latest-year revenue.

Sector
Biotechnology
Ticker
GH
Revenue (LTM)
$982M
Acquisitions
2
Operating margin
-44.5%
Latest call
Q1 2026
$982M
Revenue (LTM)
2
Acquisitions
-44.5%
Operating margin
Q1 2026
Latest call
01 Explore

Everything on Guardant Health Inc.

01
Acquisitions
Full M&A history — every deal, price and rationale.
2 deals
02
Financials
Income statement, balance sheet, cash flow and quarterly trend.
Rev $982M
03
Earnings
Quarter-by-quarter call transcripts.
4 transcripts · Q1 2026
04
People
Leadership team and board.
View

Financials

View financials

Income statement, balance sheet and cash flow for Guardant Health Inc., with quarterly trend. Latest-year revenue $982M.

Revenue (FY2025) $982M
YoY growth +32.9%
Operating margin -44.5%
Direction Expanding
Gross margin 64.5%
Net margin -42.4%

Earnings

All earnings

Quarter-by-quarter results and management commentary from the earnings calls. Most recent: Q1 2026.

Q1 2026 Transcript Q4 2025 Transcript Q3 2025 Transcript Q2 2025 Transcript

Leadership & board

View leadership

Guardant Health, Inc.'s leadership comprises 11 directors and 7 named executive officers, led by Helmy Eltoukhy (Chairperson and Co-Chief Executive Officer). Names, tenure and backgrounds are sourced from the latest SEC proxy statement (DEF 14A).

Helmy EltoukhyChairperson and Co-Chief Executive Officer
AmirAli TalasazDirector and Co-Chief Executive Officer
Ian ClarkLead Independent Director
Alex M. Azar IIDirector
Vijaya GaddeDirector
Manuel Hidalgo MedinaDirector
Meghan JoyceDirector
Steve KrognesDirector
Roberto MignoneDirector
Myrtle PotterDirector
Musa TariqDirector
Michael BellChief Financial Officer
Darya ChudovaChief Technology Officer
Craig EagleChief Medical Officer
Christopher FreemanChief Commercial Officer
Kumud KaliaChief Information Officer
Terilyn Juarez MonroeChief People Officer
John SaiaChief Legal Officer and Corporate Secretary

Acquisitions

Full history

Guardant Health Inc. has completed 2 disclosed acquisitions, largest first.

Guardant Health acquires Guardant Health AMEA, Inc. (SoftBank joint-venture buyout)International precision oncology commercialization (Asia, Middle East and Africa) · 2022 $177.8 million Guardant Health acquires MetaSight Diagnostics Ltd.Liquid-biopsy diagnostics technology / early cancer and disease detection · 2025 $93.0 million
SourcesSEC filings · company financials · earnings transcripts Last updated

More companies

CompanyRoper Technologies Inc.CompanyAMETEK Inc.CompanyFortive CorporationCompanyDover CorporationCompanyOkta Inc.CompanyDanaher Corporation

See how VectorShift works for your firm

Request Demo